Diethyl Sulfide

Diethyl Sulfide

SCHEMBL540234

B.CCSCC

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117004663-A Method for synthesizing (R) -4-propyldihydrofuran-2 (3 hydrogen) -ketone 上海颐碳化学科技有限公司 2023-11-07 CN claimed
CN-117004663-A Method for synthesizing (R) -4-propyldihydrofuran-2 (3 hydrogen) -ketone 上海颐碳化学科技有限公司 2023-11-07 CN disclosed
EP-2414350-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-02-08 EP disclosed
EP-2062856-B1 Preparation Of MnB12H12 ROHM & HAAS (US) 2011-03-16 EP disclosed
WO-2010117635-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-10-14 WO disclosed
US-7732456-B2 Pyridone derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-06-08 US disclosed
US-7563934-B2 Preparation of MnB12H12 ROHN AND HAAS COMPANY (US) 2009-07-21 US disclosed
EP-2062856-A1 Preparation Of MnB12H12 Rohm and Haas Company (US) 2009-05-27 EP disclosed
US-20090118526-A1 Where M is a metal or ammonium cation and n is one or two by combining a metal borohydride and XBH3; wherein X is an amine containing at least one aryl group, aralkyl group or branched alkyl group, a phosphine having three aryl, aralkyl or branched alkyl groups or tetrahydrofuran VERTELLUS PERFORMANCE CHEMICALS LLC 2009-05-07 US disclosed
EP-1930325-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE PIPERAZINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-06-11 EP disclosed
CN-1302116-C Process for preparing enantiomers of (1R, 4S) -or (1S, 4R) -1-amino-4- (hydroxymethyl) -2-cyclopentene derivatives LONZE AG (CH) 2007-02-28 CN disclosed
CN-1827591-A Process for preparing racemic or optically active 4- (hydroxymethyl) -2-cyclopentene derivatives LONZA AG (CH) 2006-09-06 CN disclosed
CN-1515673-A Process for preparing enantiomers of (1R, 4S) -or (1S, 4R) -1-amino-4- (hydroxymethyl) -2-cyclopentene derivatives ��¡���ӹɷ����޹�˾ 2004-07-28 CN disclosed
CN-1115343-C Process for the preparation of (1S,4R) -or (1R,4S) -4- (2-amino-6-chloro-9H-purin-9-yl) -2-cyclopentene-1-methanol or salts thereof LONZA AG (CH) 2003-07-23 CN disclosed
US-6262295-B1 REACTING CYCLOPENTENE-4-CARBOXYLIC ACID WITH AN ACYL HALIDE LONZA A.G. (CH) 2001-07-17 US disclosed
US-6252112-B1 MIBCROBIAL HYDROLYSIS OF THE TITLE COMPOUND DERIVATIVE USING ENZYME HAVING N-ACETYLAMINO-ALCOHOL HYDROLASE OR PENICILLIN G ACYLASE ACTIVITY WITH SUBSEQUENT ACYLATION LONZA A.G., (CH) 2001-06-26 US disclosed
US-6156893-A Process for the preparation of (1S,4R)- or (1R,4S)- 4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol LONZA A.G. (CH) 2000-12-05 US disclosed
US-6137007-A CHEMICAL INTERMEDIATES FOR NUCLEOSIDE, 4-2-(AMINO-6-CHLORO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL, WHICH IS AN INTERMEDIATE FOR 6-(CYCLOPROPYLAMINO)-DERIVATIVE LONZA AG (CH) 2000-10-24 US disclosed
CN-1201794-A Process for the preparation of (1S,4R) -or (1R,4S) -4- (2-amino-6-chloro-9H-purin-9-yl) -2-cyclopentene-1-methanol or salts thereof LONZA AG (CH) 1998-12-16 CN disclosed
EP-0160258-B1 (6,11-DIHYDRO-11-OXODIBENZ(BM,E)OXEPINYL)PENTANOLS, A PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-09-27 EP disclosed